197 related articles for article (PubMed ID: 32404096)
1. Rehabilitation strategies following oesophagogastric and Hepatopancreaticobiliary cancer (ReStOre II): a protocol for a randomized controlled trial.
O'Neill L; Guinan E; Doyle S; Connolly D; O'Sullivan J; Bennett A; Sheill G; Segurado R; Knapp P; Fairman C; Normand C; Geoghegan J; Conlon K; Reynolds JV; Hussey J
BMC Cancer; 2020 May; 20(1):415. PubMed ID: 32404096
[TBL] [Abstract][Full Text] [Related]
2. ReStOre@Home: Feasibility study of a virtually delivered 12-week multidisciplinary rehabilitation programme for survivors of upper gastrointestinal (UGI) cancer - study protocol.
O'Neill L; Guinan E; Brennan L; Doyle SL; O'Connor L; Sheill G; Smyth E; Fairman CM; Segurado R; Connolly D; O'Sullivan J; Reynolds JV; Hussey J
HRB Open Res; 2020; 3():86. PubMed ID: 34046552
[No Abstract] [Full Text] [Related]
3. The RESTORE Randomized Controlled Trial: Impact of a Multidisciplinary Rehabilitative Program on Cardiorespiratory Fitness in Esophagogastric cancer Survivorship.
O'Neill LM; Guinan E; Doyle SL; Bennett AE; Murphy C; Elliott JA; OʼSullivan J; Reynolds JV; Hussey J
Ann Surg; 2018 Nov; 268(5):747-755. PubMed ID: 30004915
[TBL] [Abstract][Full Text] [Related]
4. The effect of a pre- and post-operative exercise programme versus standard care on physical fitness of patients with oesophageal and gastric cancer undergoing neoadjuvant treatment prior to surgery (The PERIOP-OG Trial): Study protocol for a randomised controlled trial.
Tully R; Loughney L; Bolger J; Sorensen J; McAnena O; Collins CG; Carroll PA; Arumugasamy M; Murphy TJ; Robb WB;
Trials; 2020 Jul; 21(1):638. PubMed ID: 32660526
[TBL] [Abstract][Full Text] [Related]
5. A randomised controlled trial to assess whether prehabilitation improves fitness in patients undergoing neoadjuvant treatment prior to oesophagogastric cancer surgery: study protocol.
Allen S; Brown V; Prabhu P; Scott M; Rockall T; Preston S; Sultan J
BMJ Open; 2018 Dec; 8(12):e023190. PubMed ID: 30580268
[TBL] [Abstract][Full Text] [Related]
6. A randomised controlled trial of six weeks of home enteral nutrition versus standard care after oesophagectomy or total gastrectomy for cancer: report on a pilot and feasibility study.
Bowrey DJ; Baker M; Halliday V; Thomas AL; Pulikottil-Jacob R; Smith K; Morris T; Ring A
Trials; 2015 Nov; 16():531. PubMed ID: 26590903
[TBL] [Abstract][Full Text] [Related]
7. Preoperative exercise to improve fitness in patients undergoing complex surgery for cancer of the lung or oesophagus (PRE-HIIT): protocol for a randomized controlled trial.
Sheill G; Guinan E; O'Neill L; Normand C; Doyle SL; Moore S; Newell J; McDermott G; Ryan R; Reynolds JV; Hussey J
BMC Cancer; 2020 Apr; 20(1):321. PubMed ID: 32293334
[TBL] [Abstract][Full Text] [Related]
8. Patient and family co-developed participant information to improve recruitment rates, retention, and patient understanding in the Rehabilitation Strategies Following Oesophago-gastric and Hepatopancreaticobiliary Cancer (ReStOre II) trial: Protocol for a study within a trial (SWAT).
O'Neill L; Knapp P; Doyle SL; Guinan E; Parker A; Segurado R; Connolly D; O'Sullivan J; Reynolds JV; Hussey J
HRB Open Res; 2019; 2():27. PubMed ID: 33392438
[No Abstract] [Full Text] [Related]
9. Effects of a multimodal rehabilitation programme on inflammation and oxidative stress in oesophageal cancer survivors: the ReStOre feasibility study.
Guinan EM; Doyle SL; O'Neill L; Dunne MR; Foley EK; O'Sullivan J; Reynolds JV; Hussey J
Support Care Cancer; 2017 Mar; 25(3):749-756. PubMed ID: 27807666
[TBL] [Abstract][Full Text] [Related]
10. The CARDIA-trial protocol: a multinational, prospective, randomized, clinical trial comparing transthoracic esophagectomy with transhiatal extended gastrectomy in adenocarcinoma of the gastroesophageal junction (GEJ) type II.
Leers JM; Knepper L; van der Veen A; Schröder W; Fuchs H; Schiller P; Hellmich M; Zettelmeyer U; Brosens LAA; Quaas A; Ruurda JP; van Hillegersberg R; Bruns CJ
BMC Cancer; 2020 Aug; 20(1):781. PubMed ID: 32819399
[TBL] [Abstract][Full Text] [Related]
11. Effect of the Rehabilitation Program, ReStOre, on Serum Biomarkers in a Randomized Control Trial of Esophagogastric Cancer Survivors.
Kennedy SA; Annett SL; Dunne MR; Boland F; O'Neill LM; Guinan EM; Doyle SL; Foley EK; Elliott JA; Murphy CF; Bennett AE; Carey M; Hillary D; Robson T; Reynolds JV; Hussey J; O'Sullivan J
Front Oncol; 2021; 11():669078. PubMed ID: 34604026
[TBL] [Abstract][Full Text] [Related]
12. High-intensity interval training and energy management education, compared with moderate continuous training and progressive muscle relaxation, for improving health-related quality of life in persons with multiple sclerosis: study protocol of a randomized controlled superiority trial with six months' follow-up.
Patt N; Kool J; Hersche R; Oberste M; Walzik D; Joisten N; Caminada D; Ferrara F; Gonzenbach R; Nigg CR; Kamm CP; Zimmer P; Bansi J
BMC Neurol; 2021 Feb; 21(1):65. PubMed ID: 33573608
[TBL] [Abstract][Full Text] [Related]
13. Modular multimodal hospital-home chain physical activity rehabilitation programme (3M2H-PARP) in liver cancer: a protocol for a randomised controlled trial.
Chen H; Lu H; Zhou H; Wu B; Dong Z; Zhang S; Gu Y; Zhou G; Xiang J; Yang J
BMJ Open; 2024 May; 14(5):e083228. PubMed ID: 38772899
[TBL] [Abstract][Full Text] [Related]
14. Physical decline and its implications in the management of oesophageal and gastric cancer: a systematic review.
O'Neill L; Moran J; Guinan EM; Reynolds JV; Hussey J
J Cancer Surviv; 2018 Aug; 12(4):601-618. PubMed ID: 29796931
[TBL] [Abstract][Full Text] [Related]
15. Neoadjuvant chemoradiotherapy plus surgery versus surgery alone for oesophageal or junctional cancer (CROSS): long-term results of a randomised controlled trial.
Shapiro J; van Lanschot JJB; Hulshof MCCM; van Hagen P; van Berge Henegouwen MI; Wijnhoven BPL; van Laarhoven HWM; Nieuwenhuijzen GAP; Hospers GAP; Bonenkamp JJ; Cuesta MA; Blaisse RJB; Busch ORC; Ten Kate FJW; Creemers GM; Punt CJA; Plukker JTM; Verheul HMW; Bilgen EJS; van Dekken H; van der Sangen MJC; Rozema T; Biermann K; Beukema JC; Piet AHM; van Rij CM; Reinders JG; Tilanus HW; Steyerberg EW; van der Gaast A;
Lancet Oncol; 2015 Sep; 16(9):1090-1098. PubMed ID: 26254683
[TBL] [Abstract][Full Text] [Related]
16. Comparing open and minimally invasive surgical procedures for oesophagectomy in the treatment of cancer: the ROMIO (Randomised Oesophagectomy: Minimally Invasive or Open) feasibility study and pilot trial.
Metcalfe C; Avery K; Berrisford R; Barham P; Noble SM; Fernandez AM; Hanna G; Goldin R; Elliott J; Wheatley T; Sanders G; Hollowood A; Falk S; Titcomb D; Streets C; Donovan JL; Blazeby JM
Health Technol Assess; 2016 Jun; 20(48):1-68. PubMed ID: 27373720
[TBL] [Abstract][Full Text] [Related]
17. Physical ExeRcise Following Esophageal Cancer Treatment (PERFECT) study: design of a randomized controlled trial.
van Vulpen JK; Siersema PD; van Hillegersberg R; Nieuwenhuijzen GAP; Kouwenhoven EA; Groenendijk RPR; van der Peet DL; Hazebroek EJ; Rosman C; Schippers CCG; Steenhagen E; Peeters PHM; May AM
BMC Cancer; 2017 Aug; 17(1):552. PubMed ID: 28821284
[TBL] [Abstract][Full Text] [Related]
18. Effects of high-intensity exercise training on physical fitness, quality of life and treatment outcomes after oesophagectomy for cancer of the gastro-oesophageal junction: PRESET pilot study.
Simonsen C; Thorsen-Streit S; Sundberg A; Djurhuus SS; Mortensen CE; Qvortrup C; Pedersen BK; Svendsen LB; de Heer P; Christensen JF
BJS Open; 2020 Oct; 4(5):855-864. PubMed ID: 32856785
[TBL] [Abstract][Full Text] [Related]
19. Home-based multidimensional survivorship programmes for breast cancer survivors.
Cheng KKF; Lim YTE; Koh ZM; Tam WWS
Cochrane Database Syst Rev; 2017 Aug; 8(8):CD011152. PubMed ID: 28836379
[TBL] [Abstract][Full Text] [Related]
20. iCare - a self-directed, interactive online program to improve health and wellbeing for people living with upper gastrointestinal or hepato-pancreato-biliary cancers, and their informal carers: the study protocol for a Phase II randomised controlled trial.
Livingston PM; Winter N; Ugalde A; Orellana L; Mikocka-Walus A; Jefford M; Zalcberg J; Orford N; Hutchinson AM; Barbour A; Kiss N; Smithers BM; Watson DI; McCaffrey N; White V;
BMC Cancer; 2024 Jan; 24(1):144. PubMed ID: 38287317
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
